CN1657064A - Nasal suppository for treating thinitis - Google Patents
Nasal suppository for treating thinitis Download PDFInfo
- Publication number
- CN1657064A CN1657064A CN 200410014124 CN200410014124A CN1657064A CN 1657064 A CN1657064 A CN 1657064A CN 200410014124 CN200410014124 CN 200410014124 CN 200410014124 A CN200410014124 A CN 200410014124A CN 1657064 A CN1657064 A CN 1657064A
- Authority
- CN
- China
- Prior art keywords
- powder
- nasal obstruction
- borneolum syntheticum
- treatment
- zanthoxyli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese-medicinal nasal suppository for treating rhinitis is prepared from borneol and Chinese prickly ash through pulverizing and loading it in cylindrical plug.
Description
Technical field
The present invention relates to a kind of nasal obstruction for the treatment of rhinitis, belong to Chinese medicine product.
Background technology
Rhinitis belongs to a kind of common frdquently encountered disease, and patient age is at 12-62 between year, and teenager accounts for more than 70% of patient's total number of persons.Most of patients is by flu back sx.During morbidity, nasal obstruction, snivel or dense tears.Nasal mucosa hyperemia, edema; Part patient is with dizzy, headache.Course of disease weak point person one month perhaps reaches the several years.The treatment of methods such as common Drug therapy or freezing, the laser of performing the operation, curative effect is all undesirable, and the medical expense height, and the course of treatment is long.Bring great inconvenience and burden for patient's study, work, life.
Summary of the invention
Therefore, based on the above, the author is through concentrating on studies for many years, and repetition test has been invented a kind of nasal obstruction of the treatment rhinitis of only forming with two flavor Chinese medicines.It is cylindric and is made by the sterilization non-woven fabrics.Interior dress is through being ground into pulverous powder.The two ends of nasal obstruction have micropore, help bringing into play drug effect and be beneficial to the patient ventilative.
Nasal obstruction of the present invention is cylindric, and its two end has micropore, and pulverous Chinese medicine is housed in the cylinder: Borneolum Syntheticum, Pericarpium Zanthoxyli, the weight ratio of Borneolum Syntheticum, Zanthoxyli Bungeani powder are 0.5: 1.5-1.5: 0.5.The optimum weight ratio of described Borneolum Syntheticum powder and Zanthoxyli Bungeani powder is 1: 1.
A kind of preparation method for the treatment of the nasal obstruction of rhinitis is to be undertaken by following step:
A) Borneolum Syntheticum powder is broken into the end, the exsiccant Pericarpium Zanthoxyli of high-quality is pulverized the back cross 120 mesh sieves;
B) Pericarpium Zanthoxyli and the equivalent borneol powder mix homogeneously after sieving;
C) restrain in the nasal obstruction shell of expecting to pack into special with every 0.5.
Two flavor Chinese medicines of the present invention's nasal obstruction are selected Borneolum Syntheticum, Pericarpium Zanthoxyli for use.Make efficacy of drugs produce synergism two flavor Chinese medicine composition, thus the patient who effectively cures, troubled by slight illness for a long time.The Borneolum Syntheticum of wherein selecting for use have aroma, acrid in the mouth burn, cool in nature.Borneolum Syntheticum fragrance is good at inducing resuscitation, refreshment; Acrid in the mouth, the effect that eliminating stagnation, heat clearing away are arranged cool in nature.The Pericarpium Zanthoxyli acrid in the mouth is hot in nature, has the effect of expelling wind and cold pathogens.Two medicines share, and it is had more: the effect of inducing resuscitation, refreshment, heat clearing away, dispersing cold for relieving pain.Modern pharmacology and clinical research also prove that Borneolum Syntheticum has volatility, and easily distillation belongs to " hydroxyl terpenoid " chemical compound.Topical application does not have the minimal irritation effect slightly to sensory nerve, and certain pain relieving and gentle antisepsis are arranged.Clinical trial proof Borneolum Syntheticum has: antiinflammatory, detumescence, pain relieving, itching relieving effect; Pericarpium Zanthoxyli contains volatile oil according to chemical analysis, and contained volatile oil has local anesthesia and analgesic effect, and two medicines all have the volatilization composition, and the present invention gets the two medicines composition that effectively volatilizees.
Nasal obstruction shell of the present invention be cabinet wrap up in outward the sterilization non-woven fabrics make, be cylindric.Two ends have micropore.Can make large, medium and small three kinds of models according to patient's needs.
Nasal obstruction of the present invention through patient's application examples number reach 2000 surplus the people, follow the tracks of example surplus the statistics 200, effect is very remarkable, most of patients between period of disease with this nasal obstruction after three days, clinical symptoms obviously alleviates, seven days symptoms of continuous application disappear substantially.Case more than 95% was cured in 2 weeks.
The invention has the advantages that:
1, good effect, short treating period;
2, medication is convenient;
3, have no side effect;
4, cheap, extensive patients is easy to accept.
Below in conjunction with embodiment the present invention is described in further detail.
The specific embodiment
Embodiment 1
Pericarpium Zanthoxyli was pulverized 120 mesh sieves; Borneolum Syntheticum powder is broken into powder, then with Zanthoxyli Bungeani powder and Borneolum Syntheticum powder by 1: 1 mixed, by every nasal obstruction powder 0.5 gram of packing into, finished product.
Embodiment 2
Pericarpium Zanthoxyli was pulverized 120 mesh sieves; Borneolum Syntheticum powder is broken into powder, then with Zanthoxyli Bungeani powder and Borneolum Syntheticum powder by 0.8: 1.2 mixed, by every nasal obstruction powder 0.5 gram of packing into, finished product.
Embodiment 3
Pericarpium Zanthoxyli was pulverized 120 mesh sieves; Borneolum Syntheticum powder is broken into powder, then with Zanthoxyli Bungeani powder and Borneolum Syntheticum powder by 1.5: 0.5 mixed, by every nasal obstruction powder 0.5 gram of packing into, finished product.
Experimental example
Further set forth beneficial effect of the present invention below in conjunction with experimental example.
1, physical data
Example surplus the out-patient treatment, 2000 is followed the tracks of statistics 200 examples, and patient age is between 12-62 year, and teenager accounts for 70%; Course of disease weak point person 1 month, elder reach 12 years, and most of patients is in the flu postemphasis.
Clinical symptoms: nasal obstruction, watery nasal discharge, nasal mucosa hyperemia, edema; Part patient is with headache, nauseating, nasal sinuses district tenderness.Take the photograph sheet through the X line, CT scan has the nasal sinuses inflammation to exist.
2, criterion of therapeutical effect
A, healing: clinical symptom disappearance, nasal mucosa do not have hyperemia, edema.
B, effective: sx.
3, Therapeutic Method:
Each one, to fill in the side ventilation nostril, per 4 hours of daytime changed dressings once, and need not change dressings night.7 days is a course of treatment.
4, therapeutic effect
Treatment rate: 95%
Profitable: 100%
Claims (4)
1, a kind of nasal obstruction for the treatment of rhinitis is characterized in that nasal obstruction for cylindric, and its two end has micropore, and pulverous Chinese medicine is housed in the cylinder: Borneolum Syntheticum, Pericarpium Zanthoxyli, the weight ratio of Borneolum Syntheticum, Zanthoxyli Bungeani powder are 0.5: 1.5-1.5: 0.5.
2, the nasal obstruction of treatment rhinitis according to claim 1, the optimum weight ratio that it is characterized in that Borneolum Syntheticum powder and Zanthoxyli Bungeani powder is 1: 1.
3, a kind of method for preparing the nasal obstruction of the described treatment rhinitis of claim 1 is characterized in that being undertaken by following step:
A) Borneolum Syntheticum powder is broken into the end, the exsiccant Pericarpium Zanthoxyli of high-quality is pulverized the back cross 120 mesh sieves;
B) Pericarpium Zanthoxyli and the equivalent borneol powder mix homogeneously after sieving;
C) pack the nasal obstruction shell into special with every 0.5 gram medicated powder in.
4, the nasal obstruction of treatment rhinitis according to claim 1, it is characterized in that the shell of having a stuffy nose be plastic housing wrap up in outward the sterilization non-woven fabrics make cylindric.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410014124 CN1264544C (en) | 2004-02-20 | 2004-02-20 | Nasal suppository for treating thinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410014124 CN1264544C (en) | 2004-02-20 | 2004-02-20 | Nasal suppository for treating thinitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1657064A true CN1657064A (en) | 2005-08-24 |
| CN1264544C CN1264544C (en) | 2006-07-19 |
Family
ID=35006894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410014124 Expired - Fee Related CN1264544C (en) | 2004-02-20 | 2004-02-20 | Nasal suppository for treating thinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1264544C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1947815B (en) * | 2006-11-14 | 2012-01-25 | 吴燕斌 | Novel nasal cavity hygienic tampon and its making method |
| CN110755595A (en) * | 2019-12-12 | 2020-02-07 | 河南中医药大学 | Externally applied ganxinqin essential oil for treating allergic rhinitis |
-
2004
- 2004-02-20 CN CN 200410014124 patent/CN1264544C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1947815B (en) * | 2006-11-14 | 2012-01-25 | 吴燕斌 | Novel nasal cavity hygienic tampon and its making method |
| CN110755595A (en) * | 2019-12-12 | 2020-02-07 | 河南中医药大学 | Externally applied ganxinqin essential oil for treating allergic rhinitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1264544C (en) | 2006-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015024420A1 (en) | Local anesthesia pain-relieving time-delay agent | |
| CN1565541A (en) | Osteodynia alleviating and wind dispelling liniment | |
| CN1264544C (en) | Nasal suppository for treating thinitis | |
| CN1284585C (en) | Medicine for treating acute and chronic pharyogolaryngitis, recurring oral cavity sore and its preparation method | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN1876081A (en) | A medicinal tincture and method for preparing same | |
| CN107080786A (en) | Antidepressant compositions and its preparation method and application and medicine or pharmaceutical composition comprising it | |
| CN111821413A (en) | Traditional Chinese medicine composition for treating diarrhea and hypodynamia as well as preparation and application thereof | |
| CN101322717A (en) | Medicament composition for preventing and treating eye diseases | |
| CN100342864C (en) | Medicine for treating chronic hemorrhoids | |
| CN104666420A (en) | A medicine for treating rhinitis | |
| CN1431003A (en) | Medicine for curing cerebral concussion and injuries from falls | |
| CN1903327A (en) | Traditional Chinese medicine for treating epilepsy | |
| CN1954841A (en) | Medicine for treating chronic pharyngitis | |
| CN1277551C (en) | Mint oil preparation for treating obstructive sleep apnea and low ventilation syndrome | |
| CN1251710C (en) | Quick-effective externally used medicine for treating traumatic injury and its preparing method | |
| CN1283263C (en) | Medicine for treating rhinitis and its preparing process | |
| CN1129449C (en) | Pain treating composite medicine | |
| CN1186080C (en) | Laryngopharyngitis treating medicine | |
| CN1255132C (en) | Nasosinusitis treating medicine and its preparing process | |
| EP1669064A1 (en) | Composition and method of a topical therapy of neurodermatitis | |
| CN1736417A (en) | Composition for treating upper respiratory tract infection and application | |
| CN1358534A (en) | Compound medicine for treating bronchial asthma and preparation process | |
| CN1872233A (en) | Medical cigarette for curing toothache, and preparation method | |
| CN113599488A (en) | Traditional Chinese medicine composition for treating facial paralysis, traditional Chinese medicine preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |